Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant RecipientsJames Neuberger, Teun van Gelder, Wolf O. Bechstein et al.|Transplantation|2017Cited by 309
A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation—PROTECTLutz Fischer, Hans J. Schlitt, Philipp Neuhaus et al.|American Journal of Transplantation|2012Cited by 189